131 related articles for article (PubMed ID: 33434612)
21. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer.
Tang Z; Zhang XY; Liu Z; Li XT; Shi YJ; Wang S; Fang M; Shen C; Dong E; Sun YS; Tian J
Radiother Oncol; 2019 Mar; 132():100-108. PubMed ID: 30825957
[TBL] [Abstract][Full Text] [Related]
22. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
[TBL] [Abstract][Full Text] [Related]
23. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Laohawiriyakamol S; Worathanmanon S; Tubtawee T; Kanjanapradit K; Sangkhathat S; Pruphetkaew N; Chongsuvivatwong V
Asian J Surg; 2021 Jan; 44(1):275-279. PubMed ID: 32712044
[TBL] [Abstract][Full Text] [Related]
25. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
[TBL] [Abstract][Full Text] [Related]
26. MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer.
Ferrari R; Mancini-Terracciano C; Voena C; Rengo M; Zerunian M; Ciardiello A; Grasso S; Mare' V; Paramatti R; Russomando A; Santacesaria R; Satta A; Solfaroli Camillocci E; Faccini R; Laghi A
Eur J Radiol; 2019 Sep; 118():1-9. PubMed ID: 31439226
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.
Cercek A; Goodman KA; Hajj C; Weisberger E; Segal NH; Reidy-Lagunes DL; Stadler ZK; Wu AJ; Weiser MR; Paty PB; Guillem JG; Nash GM; Temple LK; Garcia-Aguilar J; Saltz LB
J Natl Compr Canc Netw; 2014 Apr; 12(4):513-9. PubMed ID: 24717570
[TBL] [Abstract][Full Text] [Related]
28. A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma.
Qing S; Gu L; Du T; Yin X; Zhang KJ; Zhang HJ
Technol Cancer Res Treat; 2023; 22():15330338231202893. PubMed ID: 37750231
[No Abstract] [Full Text] [Related]
29. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
[TBL] [Abstract][Full Text] [Related]
30. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of endoscopic ultrasound in staging and restaging patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Marone P; de Bellis M; Avallone A; Delrio P; di Nardo G; D'Angelo V; Tatangelo F; Pecori B; Di Girolamo E; Iaffaioli V; Lastoria S; Battista Rossi G
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):666-70. PubMed ID: 21782549
[TBL] [Abstract][Full Text] [Related]
32. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract][Full Text] [Related]
34. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
35. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
[TBL] [Abstract][Full Text] [Related]
36. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.
Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1651-60. PubMed ID: 24880919
[TBL] [Abstract][Full Text] [Related]
37. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
38. Clinical predictive factors of pathologic complete response in locally advanced rectal cancer.
De Felice F; Izzo L; Musio D; Magnante AL; Bulzonetti N; Pugliese F; Izzo P; Di Cello P; Lucchetti P; Izzo S; Tombolini V
Oncotarget; 2016 May; 7(22):33374-80. PubMed ID: 26992214
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
Dinapoli N; Barbaro B; Gatta R; Chiloiro G; Casà C; Masciocchi C; Damiani A; Boldrini L; Gambacorta MA; Dezio M; Mattiucci GC; Balducci M; van Soest J; Dekker A; Lambin P; Fiorino C; Sini C; De Cobelli F; Di Muzio N; Gumina C; Passoni P; Manfredi R; Valentini V
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):765-774. PubMed ID: 29891200
[TBL] [Abstract][Full Text] [Related]
40. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
